相关实验视频
Updated: Jan 13, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
10.0K
获得的目标变化导致对p53-Y220C反应激活器的临床耐药性
Ferran Fece de la Cruz1, Andreas Varkaris2, Parasvi S Patel3
1Massachusetts General Hospital Cancer Center Boston, MA United States.
Cancer discovery
|January 8, 2026
概括
通过二次TP53突变出现对Y220C突变p53活性剂 (如rezatapopt) 的耐药性. 这些突变阻碍了药物结合,并取消了p53的重新激活,影响了癌症治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物开发 药物开发
背景情况:
- 在癌症中,TP53基因经常发生变异,Y220C突变产生了可向的腔.
- 雷扎塔波普特是一种新型治疗剂,旨在重新激活Y220C突变p53.
研究的目的:
- 调查对Y220C突变p53活性剂耐药性的临床机制.
- 为了确定传递对rezatapopt.耐药性的二次遗传变化.
主要方法:
- 针对循环中的瘤DNA,瘤活检和尸检样本进行分析.
- 对TP53双突变的功能建模.
- 用rezatapopt.pt治疗的患者中抗药机制的分析.
主要成果:
- 在cis中与Y220C在rezatapopt进展时识别了异质的二次TP53变化.
- 这些变化包括DNA结合域和Y220C结合表面内的突变.
- 功能性研究证实了这些双重突变取消了p53的重新激活和目标基因诱导由rezatapopt.
结论:
- 建立了抗 p53 Y220C 反激剂的分子框架.
- 研究结果为开发下一代药物来克服耐药性的策略提供了信息.
- 了解耐药机制对于优化TP53向癌症疗法至关重要.
更多相关视频
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K

